Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evasion of Type I Interferon by SARS-CoV-2
Hongjie Xia, Zengguo Cao, Xuping Xie, et al.
Cell Reports (2020) Vol. 33, Iss. 1, pp. 108234-108234
Open Access | Times Cited: 931

Showing 1-25 of 931 citing articles:

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison, Lin Tao, Penghua Wang
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1100-1115
Open Access | Times Cited: 1096
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
COVID-19 and the human innate immune system
Joachim L. Schultze, Anna C. Aschenbrenner
Cell (2021) Vol. 184, Iss. 7, pp. 1671-1692
Open Access | Times Cited: 661
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Lisa Miorin, Thomas Kehrer, María Teresa Sánchez-Aparicio, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 45, pp. 28344-28354
Open Access | Times Cited: 495
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 475
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 423
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Xin Yin, Laura Riva, Yuan Pu, et al.
Cell Reports (2021) Vol. 34, Iss. 2, pp. 108628-108628
Open Access | Times Cited: 347
The variant gambit: COVID-19’s next move
Jessica A. Plante, Brooke Mitchell, Kenneth S. Plante, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 508-515
Open Access | Times Cited: 343
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Natalia Zamorano Cuervo, Nathalie Grandvaux
eLife (2020) Vol. 9
Open Access | Times Cited: 318
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar‐López, Juan J. Garrido, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 268
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery, Alan Sariol, Stanley Perlman
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 259
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
Darren P. Martin, Steven Weaver, Houriiyah Tegally, et al.
Cell (2021) Vol. 184, Iss. 20, pp. 5189-5200.e7
Open Access | Times Cited: 252
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Santhamani Ramasamy, Selvakumar Subbian
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 234
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 233
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 228
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
Antoine Rebendenne, Ana Luiza Chaves Valadão, Marine Tauziet, et al.
Journal of Virology (2021) Vol. 95, Iss. 8
Open Access | Times Cited: 214
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, et al.
Cell Reports (2021) Vol. 35, Iss. 7, pp. 109126-109126
Open Access | Times Cited: 209
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes
Yize Li, David M. Renner, Courtney E. Comar, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 16
Open Access | Times Cited: 202
Page 1 - Next Page

Scroll to top